IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD)
CUSIP: 46333X108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Common Stock
- Shares outstanding
- 163,317,295
- Total 13F shares
- 171,468,668
- Share change
- -187,609
- Total reported value
- $1,117,746,593
- Put/Call ratio
- 0.25%
- Price per share
- $6.52
- Number of holders
- 226
- Value change
- -$10,390,681
- Number of buys
- 112
- Number of sells
- 130
Quarterly Holders Quick Answers
What is CUSIP 46333X108?
CUSIP 46333X108 identifies IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 46333X108:
Top shareholders of IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
—
mixed-class rows
|
24,194,894
mixed-class rows
|
$210,465,764 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
mixed-class rows
|
19,918,024
mixed-class rows
|
$170,582,453 | — | 31 Mar 2024 | |
| Sarissa Capital Management LP |
13F
|
Company |
10%
|
16,390,000
|
$142,756,900 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
—
mixed-class rows
|
13,956,641
mixed-class rows
|
$121,272,984 | — | 31 Mar 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
4.4%
|
7,206,187
|
$62,765,889 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
7,121,557
mixed-class rows
|
$61,869,000 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
3.8%
|
6,151,001
|
$53,575,000 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.3%
|
5,400,000
|
$47,034,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.6%
|
4,235,580
|
$36,891,902 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
3,489,843
|
$30,396,533 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
mixed-class rows
|
3,306,907
mixed-class rows
|
$27,637,496 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
3,032,543
mixed-class rows
|
$26,378,109 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
1.8%
|
2,985,313
|
$26,002,077 | — | 31 Mar 2024 | |
| BROWN CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
2,700,705
|
$23,523,141 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
2,679,153
mixed-class rows
|
$23,327,832 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
1,843,243
|
$16,054,647 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.99%
|
1,625,000
|
$14,153,750 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
mixed-class rows
|
1,554,258
mixed-class rows
|
$13,378,442 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.93%
|
1,517,726
|
$13,219,393 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.91%
|
1,479,964
|
$12,890,486 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
1,392,403
|
$12,127,830 | — | 31 Mar 2024 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.85%
|
1,390,627
|
$12,112,361 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.84%
|
1,379,662
|
$12,016,856 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.8%
|
1,312,244
|
$11,429,644 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.79%
|
1,285,000
|
$11,192,350 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.73%
|
1,188,233
|
$10,349,509 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
mixed-class rows
|
1,185,378
mixed-class rows
|
$10,323,523 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.64%
|
1,037,418
|
$9,035,911 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.62%
|
1,017,819
|
$8,865,203 | — | 31 Mar 2024 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
0.61%
|
1,002,225
|
$8,729,380 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.58%
|
947,710
|
$8,254,554 | — | 31 Mar 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.58%
|
944,912
|
$8,230,184 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
906,316
mixed-class rows
|
$7,893,815 | — | 31 Mar 2024 | |
| Hodges Capital Management Inc. |
13F
|
Company |
0.53%
|
863,500
|
$7,521,000 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.52%
|
850,000
|
$7,403,500 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.51%
|
833,274
|
$7,257,817 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.5%
|
822,749
|
$7,166,144 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.5%
|
809,002
|
$7,046,407 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.49%
|
804,900
|
$7,010,680 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.48%
|
777,847
|
$6,775,044 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.4%
|
649,179
|
$5,654,349 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.39%
|
644,153
|
$5,610,573 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.38%
|
618,528
|
$5,387,379 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.38%
|
612,600
|
$5,335,746 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
612,407
|
$5,334,066 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.36%
|
591,004
|
$5,147,645 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.35%
|
572,500
|
$4,986,475 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
516,963
|
$4,502,748 | — | 31 Mar 2024 | |
| Jason Rickard |
3/4/5
|
SVP, Chief Operating Officer |
—
mixed-class rows
|
398,150
mixed-class rows
|
$4,210,976 | — | 08 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
469,742
|
$4,091,453 | — | 31 Mar 2024 |
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2024
As of 30 Jun 2024,
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) was held by
226 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,468,668 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Sarissa Capital Management LP, STATE STREET CORP, Pacer Advisors, Inc., RENAISSANCE TECHNOLOGIES LLC, ARMISTICE CAPITAL, LLC, LSV ASSET MANAGEMENT, MORGAN STANLEY, and BRAIDWELL LP.
This page lists
225
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
259
Q2 2024 holders
226
Holder diff
-33
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.